NATURAL PRODUCTS SERIES I
ANTICANCER DRUGS
cat # natProducts/anticancer
NOTE: THIS SERIES, WHICH WAS ANNOUNCED, WAS CANCELLED. IF YOU DO HAVE AN INTEREST IN THIS SERIES OR ON A PARTICULAR DRUG, DO CONTACT US.
This series focuses on technology and global market studies of anticancer natural products. It provides global market information and technology discussion on 7 important natural anticancer products.
Each report is about 100-200 pages (depending upon the product).
Typical report has the following details (although the exact details may vary depending on the product):
 Executive Summary
Introduction
Overview
Technology
End-User Scenario
Market Information
Regulations
Industry Trends
Technology Development and Patent Analysis
Major Players
Future Outlook And Recommendation
More detailed information about the report is given below.
The seven products in this series are as follows:
1. Taxol
Belongs to the family of drugs called mitotic inhibitors. It is obtained via a semi-synthetic process from Taxus baccata and other species of Taxus (Yew trees). It is approved for treating certain cancers like breast cancer, ovarian cancer, and lung cancer.
|
2. Vinblastine
Belongs to the family of plant drugs called vinca alkaloids. It is a mitotic inhibitor. Vinblastine alkaloid is extracted from Catharanthus roseus. It is used in the treatment for some types of cancer including leukaemia, lymphoma, breast and lung cancer.
|
3.
Vincristine
Belongs to the family of plant drugs called vinca alkaloids. Vincristine alkaloid is extracted from Catharanthus roseus, belonging to the family Apocynaceae. This species is also known as Vinca rosea and has the alternative common name of Vinca. Vincristine is an alkaloid derived from flowering periwinkle. Vincristine is used as a chemotherapeutic agent for some types of cancers including leukaemia, lymphoma, breast and lung cancer.
|
4. Topotecan (a camptothecin derivative)
Belongs to the family of drugs called topoisomerase inhibitors. It is also called Hycamtin. Camptothecin, a quinoline-based alkaloid is isolated from Nothapodytes foetida. It has been approved for ovarian cancer therapy.
|
5. Irinotecan
Belongs to a family of drugs called topoisomerase inhibitors. It is a camptothecin analog and isolated from Nothapodytes foetida. Also called CPT 11. It is approved for metastatic colorectal cancers.
|
6.
Etoposide
Belongs to the families of drugs called podophyllotoxin derivatives and topoisomerase inhibitors. Etoposide is a semisynthetic derivative of the podophyllotoxins, an epipodophyllotoxin. It is used in treating various types of cancers including bladder cancer, brain tumours, cervical cancer, ependyoma, germ cell tumor and gestational trophoblastic neoplasia.
|
7.
Teniposide
Belongs to the family of drugs called mitotic inhibitors. Teniposide is a semisynthetic podophyllotoxin derived from the root of Podophyllum peltatum (the May apple or mandrake). It is used for treating Acute lymphocytic leukemia and neuroblastoma.
|
Complete Natural Series I- Anticancer Drugs (7 technology and market research reports of naturally derived anticancer drugs) at US$15,000 (pre-publication price of US$ 13,000). Add to the cart below.
You may also order by fax. See instructions here.
More Detailed Information of Each Report
SUMMARY
INTRODUCTION
- Objectives and Goals of the study
- Reasons for the study
- Scope of the Study
- Targeted Audience
- Methodology
- Credentials of the analyst
- List of Natural products covered
OVERVIEW
- General Background
- Product Application
- Historical timeline of the product
- Major producing countries
- Cultivation of the plant species
- Global Scenario-Supply and technology trends
TECHNOLOGY
- Plant Cultivation practices
- Status of agricultural biotechnology research in different regions
- Extraction and isolation of active ingredients
- Alternate process in use
- Semisynthesis of the active ingredients
- Formulation
- Quality Standards and testing procedures
- End-user scenario
- Application of the product in cancer treatment
- Recent Developments in the end-user sector
- Substitution possibility of the product in the end-user sector
MARKET INFORMATION
- Worldwide current and projected demand for end-user sector (2006-2011)
- Demand drivers
- Current and projeced worlwide demand of the product by the end-use sector (2006-2011)
- Current and projected worldwide demand for product by regions (2006-2011). Covers Americas, Europe, Asia Pacific, and other regions
REGULATIONS
- Important Natural products promotional organizations
- Guidelines of World Health Organization
- US Food and Drugs Act
- European Union Regulations
- Regulations in Asia-Pacific
INDUSTRY TRENDS
- Consumption norms and usage practices in different regions
- Environmental issues and side effects
- Trade practices
- Pricing trends
- Consumer's preference and priorities
- Cultivation practices and norms by regions
TECHNOLOGY DEVELOPMENT AND PATENT ANLYSIS
- Recent technology developments in processing and applications
- Patent analysis
- Summary of important patents
MAJOR PLAYERS
- Market share of Major players
- Profile of major players and their product range/ specifications
- Research and development initiatives
- Global mergers and acquisitions
- New projects under planning/ implementation
FUTURE OUTLOOK AND RECOMMENDATIONS
- SWOT analysis
- Futuristic prospects and region wise trends
- Recommendations
LIST OF IMPORTANT TABLES
- Table 1. Worldwide demand through 2011
- Table 2. Origin, Botanical Traits and Constituent of the product
- Table 3. Timeline of important events in usage of the product
- Table 4. Area of cultivation and yield per hectare
- Table 5. Manufacturing technology and benefits
- Table 6. Drug development and Formulations
- Table 7. World demand for end-user sector in 2006, through 2011
- Table 8. Sector wise/Application wise demand for the product in 2006, through 2011
- Table 9. Worldwide demand for the product in 2006, through 2011
- Table 10. Demand in North America in 2006, through 2011 (million/metric tonnes)
- Table 11. Demand in Europe in 2006, through 2011 (million/metric tonnes)
- Table 12. Demand in Asia pacific in 2006, through 2011 (million/metric tonnes)
- Table 13. Demand in other region in 2006, through 2011 (million/metric tonnes)
- Table 14. Patent analysis
- Table15. Market share of major players in percentage
- Table 16. Product specifications
LIST OF IMPORTANT FIGURES
- Figure 1. Worldwide demand through 2011
- Figure 2. World demand for end-user sector in 2006, through 2011
- Figure 3. Pattern of sector wise/Application wise demand for the product in 2006
- Figure 4. Worldwide demand for the product in 2006, through 2011
- Figure 5. Demand in North America in 2006, through 2011
- Figure 6. Demand in Europe in 2006, through 2011
- Figure 7. Demand in Asia pacific in 2006, through 2011
- Figure 8. Demand in other region in 2006, through 2011)
- Figure 9. Pattern of market share of major players in 2006
Also check out our other reports and directories..
 NEW Our ReadyReports - Off-the shelf multiclient studies
NEW Natural Products Series Featured Reports and Investment Opportunities
Agricultural Directories International Directories
Indian Directories
Chemical Directories
Pharmaceutical / Biotech / BioMed Directories
Custom Manufacturers Directories
Herbal Directories
Agro / Food Industry Directories
Consultant / Service Provider Directories
Infrastructure Directories
Our Other products and services include:
Global Product Profiles
Global Project Reports
Global Market Research and Analysis
Nandini Chemical Journal
See Our Refund Policy
|
Anticaner Drugs 
